B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Bgt 226 Free Base

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bgt 226 Free Base, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

sapanisertib
6 shared targets
omipalisib
7 shared targets
gedatolisib
6 shared targets
pf
6 shared targets
vistusertib
6 shared targets
bimiralisib
6 shared targets
voxtalisib
5 shared targets
gsk
10 shared targets
idelalisib
5 shared targets
pilaralisib
5 shared targets
Loading evidence profile...

This evidence profile for Bgt 226 Free Base is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.